Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBiocryst Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | $0.01 | $0.07 | $0.04 |
| Q2 2026 | 2 | $0.10 | $0.14 | $0.13 |
| Q3 2026 | 2 | $0.03 | $0.05 | $0.04 |
| Q4 2026 | 1 | $0.06 | $0.08 | $0.06 |
| Q1 2027 | 1 | $0.05 | $0.07 | $0.06 |
| Q2 2027 | 1 | $0.10 | $0.13 | $0.11 |
| Q3 2027 | 1 | $0.11 | $0.15 | $0.13 |
| Q4 2027 | 1 | $0.12 | $0.16 | $0.13 |
Biocryst Pharmaceuticals Inc. Earnings Date And Information
Biocryst Pharmaceuticals Inc. last posted its earnings results on Wednesday, May 6th, 2026. The company reported $-0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by $0.09. The company had revenue of 156.41 M for the quarter and had revenue of 874.84 M for the year. Biocryst Pharmaceuticals Inc. has generated $1 earnings per share over the last year ($1.21 diluted earnings per share) and currently has a price-to-earnings ratio of -5.09. Biocryst Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Biocryst Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2026 | Q1 2026 | $0.06 | -$2.98 | -3.04 | $151.12 M | $156.41 M |
| 02/26/2026 | Q4 2025 | $0.07 | $1.17 | 1.1 | $151.32 M | $406.56 M |
| 11/04/2025 | Q3 2025 | N/A | $0.06 | N/A | $162.97 M | $159.40 M |
| 08/05/2025 | Q2 2025 | N/A | $0.02 | N/A | $149.82 M | $163.35 M |
| 05/06/2025 | Q1 2025 | N/A | $0.00 | N/A | $127.79 M | $145.53 M |
| 02/25/2025 | Q4 2024 | N/A | -$0.13 | N/A | $130.15 M | $131.53 M |
| 11/05/2024 | Q3 2024 | N/A | -$0.07 | N/A | $113.99 M | $117.09 M |
| 08/06/2024 | Q2 2024 | N/A | -$0.06 | N/A | $98.30 M | $109.33 M |
| 05/07/2024 | Q1 2024 | N/A | -$0.17 | N/A | $85.62 M | $92.76 M |
| 02/27/2024 | Q4 2023 | N/A | -$0.31 | N/A | N/A | $93.40 M |
| 11/08/2023 | Q3 2023 | N/A | -$0.19 | N/A | N/A | $86.74 M |
| 08/07/2023 | Q2 2023 | N/A | -$0.40 | N/A | N/A | $82.49 M |
| 05/08/2023 | Q1 2023 | N/A | -$0.28 | N/A | N/A | $68.78 M |
| 02/27/2023 | Q4 2022 | N/A | -$0.38 | N/A | N/A | $79.55 M |
| 11/04/2022 | Q3 2022 | N/A | -$0.23 | N/A | N/A | $75.83 M |
| 08/05/2022 | Q2 2022 | N/A | -$0.32 | N/A | N/A | $65.53 M |
| 05/09/2022 | Q1 2022 | N/A | -$0.40 | N/A | N/A | $49.92 M |
| 02/28/2022 | Q4 2021 | N/A | -$0.10 | N/A | N/A | $47.16 M |
| 11/04/2021 | Q3 2021 | N/A | -$0.33 | N/A | N/A | $40.99 M |
| 08/09/2021 | Q2 2021 | N/A | -$0.24 | N/A | N/A | $49.96 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biocryst Pharmaceuticals Inc. Earnings: FAQ's
The conference call for Biocryst Pharmaceuticals Inc.'s latest earnings report can be listened to online.
The conference call transcript for Biocryst Pharmaceuticals Inc.'s latest earnings report can be read online.
Biocryst Pharmaceuticals Inc. (:BCRX) has a recorded annual revenue of $874.84 M.
Biocryst Pharmaceuticals Inc. (:BCRX) has a recorded net income of $263.86 M.Biocryst Pharmaceuticals Inc. has generated $1.26 earnings per share over the last four quarters.
Biocryst Pharmaceuticals Inc. (:BCRX) has a price-to-earnings ratio of -5.09 and price/earnings-to-growth ratio is 0.